ProCE Banner Activity

Optimizing Management of Patients With Cardiometabolic and Renal Disease: A Case-Based Multidisciplinary Discussion

Slideset

Download these slides for expert reviews on the role of SGLT2 inhibitors in cardiometabolic and renal disease.

Released: December 09, 2022

Expiration: December 08, 2023

Share

Provided by

ProCE Banner

Partners

Academy of Physician Associates in Cardiology

ProCE Banner

Faculty Disclosure

Jennifer B. Green MD: consultant/advisor/speaker: Anji, AstraZeneca, Bayer, Boehringer Ingelheim/Lilly, Novo Nordisk, Pfizer, Sanofi/Lexicon, Valo, Vertex; researcher: Boehringer Ingelheim/Lilly, Merck, Roche.

Viet Le, MPAS, PA-C: researcher (paid to institution): Amarin, Lilly, Milestone, Novartis

Matthew Weir, MD: advisor: Akebia, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novo Nordisk, Vifor.

Additional Information

Program Medium

This program has been made available online.